Primary Care Clinics in Milford, MI Accepting Medicare
7 Primary Care Clinics found. Showing 1 - 7
 Milford Family Practice Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1265 N Milford Rd, Milford, MI 48381 Phone: 248-685-3600 Fax: 248-685-0368 |
Debra M Vanort Do Pc Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1501 N Milford Rd, Suite 100, Milford, MI 48381 Phone: 248-676-8110 Fax: 248-676-8118 |
Milford Urgent Care, P.c Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 414 Union St Ste 101, Milford, MI 48381 Phone: 248-714-9751 Fax: 248-714-9762 |
Kastytis Buitkus Md Pc Clinic/Center - Primary Care Medicare: Not Enrolled in Medicare Practice Location: 1265 North Milfordn Rd, Milford, MI 48381 Phone: 248-685-2222 |
Nextgen Physicians Plc Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 414 Union St, Suite 100, Milford, MI 48381 Phone: 248-676-8889 Fax: 248-685-8039 |
Oakland Internal Medicine Associates Pc Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1435 N Milford Rd, Ste 101, Milford, MI 48381 Phone: 248-685-9780 Fax: 248-684-8851 |
Milford Urgent Care, P.c Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 414 Union St Ste 101, Milford, MI 48381 Phone: 248-714-9751 Fax: 248-714-9762 |
News Archive
VisEn Medical acquires Bayer Schering Pharma AG's fluorescence agent intellectual property portfolios
VisEn Medical Inc., a leader in fluorescence in vivo imaging from research through medicine, announced today that it has acquired the fluorescence imaging agent intellectual property portfolios and related technology platforms from Bayer Schering Pharma AG, Germany.
Living liver donors at risk from life-threatening "near-miss" events?
A study published in Liver Transplantation, a journal of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, reports that donor mortality is about 1 in 500 donors with living donor liver transplantation (LDLT).
NHI first-quarter normalized FFO increases to $17.17M, net income to $15.94M
National Health Investors, Inc. announced today its normalized Funds From Operations ("FFO") and net income for the three months ended March 31, 2010.
Research suggests new pathway for preventing optic nerve damage in KPro recipients
Researchers from Massachusetts Eye and Ear/Harvard Medical School have identified inflammatory factors that cause optic neuropathy in the back of the eye following implantation of a keratoprosthesis (KPro) — similar to what glaucoma patients experience, without the rise of pressure in the eye — and have shown that blocking one of those factors, tumor necrosis factor alpha (TNFa), successfully halts the development of optic nerve damage in a mouse model.
› Verified 4 days ago